| Title |
Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses
|
|---|---|
| Published in |
BMC Psychiatry, February 2013
|
| DOI | 10.1186/1471-244x-13-58 |
| Pubmed ID | |
| Authors |
Paul Geerts, Guadalupe Martinez, Andreas Schreiner |
| Abstract |
Discontinuation of antipsychotic treatment for schizophrenia can interrupt improvement and exacerbate the illness. Reasons for discontinuing treatment are multifactorial and include adherence, efficacy and tolerability issues. Poor adherence may be addressed through non-pharmacological approaches as well as through pharmacological ones, ie ensured delivery of medication, such as that achieved with long-acting injectable (LAI) antipsychotics. However, attitudes of healthcare professionals (HCPs) towards LAI antipsychotics may influence their prescribing decisions and may influence medication choices offered to patients. We therefore conducted a survey to investigate factors driving LAI use as well as physician and nurse attitudes to LAI antipsychotics and to different injection sites. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Egypt | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 113 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 17 | 15% |
| Student > Bachelor | 15 | 13% |
| Student > Master | 12 | 10% |
| Researcher | 11 | 9% |
| Other | 10 | 9% |
| Other | 24 | 21% |
| Unknown | 27 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 20% |
| Psychology | 20 | 17% |
| Nursing and Health Professions | 19 | 16% |
| Neuroscience | 5 | 4% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 14 | 12% |
| Unknown | 32 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2013.
All research outputs
#14,162,589
of 22,696,971 outputs
Outputs from BMC Psychiatry
#3,019
of 4,642 outputs
Outputs of similar age
#109,493
of 191,530 outputs
Outputs of similar age from BMC Psychiatry
#68
of 98 outputs
Altmetric has tracked 22,696,971 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,642 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,530 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.